Overview

Noradrenalin vs Terlipressin in Hepatorenal Syndrome

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether noradrenalin is as effective and safe as terlipressin in the treatment of hepatorenal syndrome
Phase:
Phase 3
Details
Lead Sponsor:
University of Turin, Italy
Treatments:
Lypressin
Norepinephrine
Terlipressin